Articles From: Idera Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Corporate Update to FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test


Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleic acid therapeutics for rare diseases, today reported financial and operational results for the quarter ended June 30, 2014.
Sign-up for Idera Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Corporate Update investment picks
2014/8/12
-- Revenue Growth of 30.7% YoY -- --
Sign-up for China XD Plastics Announces Second Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201408/TN-268941_TASERAXONflexCamerawithControllerandOakleyFlakJacketGlasses.jpeg.jpg TASER's AXON Flex Body-Worn Video Camera http://media.marketwire.com/attachments/201103/40696_taser_logo_portrait_light_brand_bgcopy.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1137100&ProfileId=051205&sourceType=1 SEATTLE, WA --
Sign-up for Fresno Police Department Expands Body-Worn Camera Program With Purchase of 100 Cameras From TASER investment picks
2014/8/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0956836005&sourceType=1 http://www.ccnmatthews.com/logos/20060929-Rona2.jpg BOUCHERVILLE, QUEBEC --
Sign-up for REMINDER/Release of RONA's 2014 Second Quarter Financial Results investment picks
BEIJING, Aug.
Sign-up for ChinaNet Online Holdings Signed Agreement With Baidu investment picks
http://media.marketwire.com/attachments/201205/45530_fortegra.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1137088&ProfileId=051205&sourceType=1 NEW YORK, NY and JACKSONVILLE, FL --
Sign-up for Tiptree Financial Inc. to Acquire Fortegra Financial Corporation for $10.00 per Share in Cash investment picks
Tiptree Financial Inc. (NASDAQ:TIPT) (“Tiptree”) and Fortegra Financial Corporation (NYSE:FRF) (“Fortegra”) today jointly announce the signing of a merger agreement pursuant to which Tiptree will acquire Fortegra in an all cash transaction valued at approximately $218 million.
Sign-up for Tiptree Financial Inc. to Acquire Fortegra Financial Corporation for $10.00 per Share in Cash investment picks
MSCI Inc. (NYSE:MSCI), a leading provider of investment decision support tools worldwide, announced today that it has completed the acquisition of GMI Ratings through its subsidiary MSCI ESG Research Inc. GMI Ratings is a provider of corporate governance research and ratings on over 6,000 companies worldwide.
Sign-up for MSCI Completes Acquisition of GMI Ratings investment picks
GAITHERSBURG, Md.
Sign-up for GenVec Reports Second Quarter 2014 Financial Results investment picks
The Valspar Corporation (NYSE: VAL) today reported fiscal third quarter 2014 net sales of $1.2 billion, an increase of 10 percent over the prior year.
Sign-up for Valspar Reports Fiscal 2014 Third Quarter Results investment picks
Agilysys, Inc. (Nasdaq:AGYS), a leading provider of innovative information technology and hospitality software and services, today announced that SUNY Cobleskill Auxiliary Services in Cobleskill, NY, has selected the Agilysys Eatec® inventory and procurement system and the Agilysys InfoGenesis™ POS system to streamline its foodservice operations.
Sign-up for SUNY Cobleskill Auxiliary Services Implements Agilysys Solutions to Improve Operations, Enhance Guest Service investment picks
2014/8/12
By Carla Mozee, MarketWatch Hargreaves Lansdown hurt on rating view -Carla Mozee; 415-439-6400; AskNewswires@dowjones.com LONDON (MarketWatch) -- Shares of Prudential PLC outperformed the broader U.K. stock market Tuesday as the insurer said it will increase a dividend.
Sign-up for UPDATE: Prudential shares rise in London after dividend lift investment picks
2014/8/12
Jackson National Life Insurance Company ® (Jackson ® ) generated a record $1.1 billion in IFRS pretax operating income 1 during the first half of 2014, an increase of 20 percent over the first half of 2013.
Sign-up for Jackson Reports Record First Half Results investment picks
Reports revenue growth of 69% year-over-year Reports non-GAAP diluted EPS of $0.13, a 79% increase over last year Issues full year 2014 revenue guidance of $18.0 million to $18.2 million Closes on IPO and completes move into new facility WINTER SPRINGS, Fla., Aug.
Sign-up for IRADIMED CORPORATION Announces Second Quarter 2014 Financial Results investment picks
NEW YORK (MarketWatch) -- Shares of Flowers Foods (FLO) tumbled 8.8% to $18.25 in premarket trade Tuesday after the packaged bakery goods company reported disappointing second-quarter results amid high promotional activity and increased competition.
Sign-up for Flowers Foods shares drop after profit, sales miss forecasts investment picks
SAN DIEGO, Calif., Aug.
Sign-up for Cubic Awarded $1.8 Million Contract to Supply Common Data Link for Small Unmanned Aircraft Systems investment picks
By Angela Johnson, MarketWatch These are the stocks to watch before Tuesday's opening bell: Kate Spade & Co.
Sign-up for UPDATE: Tesla, Kate Spade are Tuesday's stocks to watch investment picks
EQT Corporation’s (NYSE: EQT) chairman, president and CEO, David Porges, is scheduled to present at EnerCom’s Oil & Gas Conference 2014 on Tuesday, August 19 --
Sign-up for EQT to Present at EnerCom’s Oil & Gas Conference 2014 investment picks
CST Brands, Inc. (NYSE: CST), one of the largest independent retailers of motor fuels and convenience merchandise in North America, today reported financial results for the second quarter ended June 30, 2014.
Sign-up for CST Brands, Inc. Reports Second Quarter 2014 Results investment picks
Sales of flagship PIFA Heparin/PF4 products increasing THOROFARE, N.J., Aug.
Sign-up for Akers Biosciences Reports Its Second Quarter Financial Results investment picks
Starwood Waypoint Residential Trust (NYSE:SWAY) (“the Company”), a leading single-family rental real estate investment trust (“REIT”), announced today that it completed the acquisition of two separate pools of non-performing loans (“NPLs”) for a total purchase price of $218.7 million.
Sign-up for Starwood Waypoint Residential Trust Purchases Two Pools of Non-Performing Loans and REOs investment picks
Retrophin, Inc. (NASDAQ:RTRX) today reported its financial results for the quarter ended June 30, 2014.
Sign-up for Retrophin Reports Second Quarter 2014 Financial Results investment picks
Net Cash from operating activities of US$ 6.1 million in Q2 2014 YAVNE, Israel , Aug.
Sign-up for G. Willi-Food Reports H1 2014 sales down 0.5% FROM H1 2013 sales investment picks
Second Quarter 2014 and Recent Highlights - as compared to the prior year quarter: - UDF IV shares began trading on NASDAQ Global Select Market (NASDAQ) on June 4, 2014 under the ticker UDF - Completed tender offer of $35 million for approximately 1.7 million shares at $20.50 per share in July, 2014 - Net interest income after provision for loan losses increased 59% to $16.8 million - Net income increased 86% to $11.4 million - Earnings per share increased 52% to $0.35 - Investments in loan participation interest and notes receivable increased 51% to $560.6 million - Balances drawn on lines of credit increased to $73.2 million from $12.3 million GRAPEVINE, Texas , Aug.
Sign-up for United Development Funding IV Reports Second Quarter 2014 Financial Results investment picks
SAN DIEGO, Aug.
Sign-up for Kratos Team Awarded $38.7 Million Contract investment picks
Array planning for potential return of MEK inhibitor BOULDER, Colo.
Sign-up for Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 investment picks
First time in history a technology receives FDA approval and proposed national coverage by CMS on the same day Screening test detects 92% of colorectal cancer MADISON, Wis.
Sign-up for FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Idera Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Corporate Update to FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices